Inozyme Pharma, Inc. Quarterly Return On Assets in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Inozyme Pharma, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q3 2024.
  • Inozyme Pharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -57 %, a 33.3% decline year-over-year.
  • Inozyme Pharma, Inc. annual Return On Assets for 2023 was -40.7 %, a 14.4% increase from 2022.
  • Inozyme Pharma, Inc. annual Return On Assets for 2022 was -47.6 %, a 19.4% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -57 -14.3 -33.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -47.9 -1.57 -3.39% Apr 1, 2024 Jun 30, 2024
Q1 2024 -42 +3.28 +7.24% Jan 1, 2024 Mar 31, 2024
Q4 2023 -40.7 +6.84 +14.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -42.8 +6.3 +12.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -46.4 +2.63 +5.37% Apr 1, 2023 Jun 30, 2023
Q1 2023 -45.3 +2.91 +6.04% Jan 1, 2023 Mar 31, 2023
Q4 2022 -47.6 -7.71 -19.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -49.1 -17.2 -53.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -49 -10.7 -27.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.2 -6.69 -16.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -39.8 Oct 1, 2021 Dec 31, 2021
Q3 2021 -31.9 Jul 1, 2021 Sep 30, 2021
Q2 2021 -38.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 -41.5 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.